{"id":"W4386954679","doi":"10.1016/j.cgh.2023.09.010","title":"Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)","year":2023,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"National Institutes of Health; Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.","keywords":"Medicine; Adalimumab; Internal medicine; Vedolizumab; Crohn's disease; Adverse effect; Gastroenterology; Clinical endpoint; Placebo; Combination therapy; Methotrexate; Surgery; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006256718,0.0001808112,0.0003072387,0.000113697,0.00007339366,0.00001162221,0.0001278574,0.0002433996,0.00001867282],"category_scores_gemma":[0.0002437776,0.0001763077,0.0000833151,0.00005918387,0.0005408741,0.000007773398,0.0001937715,0.0002059001,0.00001958172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007105225,"about_ca_system_score_gemma":0.00005345205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006024775,"about_ca_topic_score_gemma":0.0001367379,"domain_scores_codex":[0.9978015,0.0007301844,0.0004543648,0.0005584063,0.00005742611,0.0003981561],"domain_scores_gemma":[0.9992535,0.00009080792,0.0001017507,0.0002726621,0.00004349703,0.0002377546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004615636,0.00013919,0.9902031,0.00001750991,0.00004933437,0.0006098408,0.00003578411,0.00000463891,0.0002028482,0.0003988133,0.0007383545,0.002984925],"study_design_scores_gemma":[0.003858434,0.0005442264,0.9923224,0.000007008015,0.00001759403,0.00002292628,0.00002683983,0.000595593,0.00001856834,0.001265811,0.00121502,0.000105555],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979045,0.0002273311,0.00005978036,0.001211774,0.0002794159,0.0002346522,0.00001665213,0.00003411022,0.00003179882],"genre_scores_gemma":[0.9939092,0.003056037,0.00007125335,0.002596264,0.00008839623,0.00007425684,0.0001163746,0.00002091533,0.0000672752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003995257,"threshold_uncertainty_score":0.7189621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03671943648637237,"score_gpt":0.3299430247459963,"score_spread":0.2932235882596239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}